Bills › 89th General Assembly
Relating to insurance coverage for prescription drugs used in the treatment of stage IV cancer, and including applicability provisions
Where it is now
- Done: IntroducedApril 21, 2021
- Stopped: SubcommitteeDied when the General Assembly ended
- Next: House committee
- Next: Passes the House
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2022 session adjourned on May 24, 2022, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to insurance coverage for prescription drugs used in the treatment of stage IV cancer. The bill requires policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs to provide coverage for prescription cancer drugs. “Prescription cancer drug” is defined in the bill as a prescription drug that is used to treat stage IV cancer. “Stage IV cancer” is also defined in the bill. The policy, contract, or plan is required to provide coverage, without imposing a step therapy protocol, for a prescription cancer drug that has been approved by the United States food and drug administration, the use of which is in accordance with medical standards of care for stage IV cancer, and the use of which is supported by peer-reviewed, evidence-based literature.
Read the full explanation
The policy, contract, or plan must provide coverage, and may impose a step therapy protocol, for a prescription drug that is used to treat “associated conditions”. “Associated conditions” is defined in the bill as symptoms or side effects associated with stage IV cancer, or with the health care services for stage IV cancer provided by a covered person’s health care professional. “Step therapy protocol” is defined in the bill as a protocol or program that establishes a specific sequence in which prescription drugs for a specified medical condition and medically appropriate for a particular covered person are covered under a pharmacy or medical benefit by a health carrier, a health benefit plan, or a utilization review organization, including self-administered drugs and drugs administered by a health care professional. The bill applies to the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill. The provisions of the bill are applicable to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2022.
Iowa Code it changes
Creates§514C.24A
Lobbying
0 for · 0 against · 1 undecided · Who →
Family tree
Tried before
89th General Assembly
Earlier and later bills are matched by wording or an identical title.
Tried before
This idea has been filed in an earlier General Assembly. None got through a chamber.
- SF 2384 Relating to insurance coverage for prescription drugs used in the treatment of stage IV ca…88th General Assembly · Approved by committee · same titleCleared committee
Similar bills this General Assembly
- SSB 1009 SSB 100990th General Assembly · Subcommittee recommends passageSimilar
- SF 2165 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …89th General Assembly · In committeeSimilar
- SF 197 Relating to insurance coverage for prescription drugs used in the treatment of metastatic …91st General Assembly · Subcommittee recommends passageSimilar
Matched by wording or an identical title.